BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35092731)

  • 1. Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway.
    Zhu M; Niu J; Jiang J; Dong T; Chen Y; Yang X; Liu P
    Life Sci; 2022 Mar; 293():120358. PubMed ID: 35092731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT/ERK1/2/STAT3-SOX2/Snail signaling pathway.
    Chen Y; Niu J; Li L; Li Z; Jiang J; Zhu M; Dong T; Zhang J; Shi C; Xu P; Lu Y; Jiang Y; Liu P; Chen W
    Life Sci; 2020 Oct; 258():118158. PubMed ID: 32750435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
    Li Z; Chen Y; An T; Liu P; Zhu J; Yang H; Zhang W; Dong T; Jiang J; Zhang Y; Jiang M; Yang X
    J Exp Clin Cancer Res; 2019 Mar; 38(1):139. PubMed ID: 30922391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme.
    Chen Y; Liu P; Sun P; Jiang J; Zhu Y; Dong T; Cui Y; Tian Y; An T; Zhang J; Li Z; Yang X
    Theranostics; 2019; 9(5):1453-1473. PubMed ID: 30867843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathway.
    Chen X; Zhu M; Zou X; Mao Y; Niu J; Jiang J; Dong T; Shi Y; Yang X; Liu P
    Life Sci; 2022 Dec; 311(Pt B):121174. PubMed ID: 36396110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion.
    Joseph JV; Conroy S; Tomar T; Eggens-Meijer E; Bhat K; Copray S; Walenkamp AM; Boddeke E; Balasubramanyian V; Wagemakers M; den Dunnen WF; Kruyt FA
    Cell Death Dis; 2014 Oct; 5(10):e1443. PubMed ID: 25275602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway.
    Chen W; Kong KK; Xu XK; Chen C; Li H; Wang FY; Peng XF; Zhang Z; Li P; Li JL; Li FC
    Int J Oncol; 2018 Feb; 52(2):485-495. PubMed ID: 29345288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
    Zhou X; Lv L; Tan Y; Zhang Z; Wei S; Xiao S
    Brain Res; 2021 Sep; 1766():147515. PubMed ID: 33984327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
    Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
    Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK/AKT pathway.
    Zhu YG; Lv YX; Guo CY; Xiao ZM; Jiang QG; Kuang H; Zhang WH; Hu P
    Life Sci; 2021 Apr; 270():119112. PubMed ID: 33508300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L; Li G; Li R; Liu Q; He Q; Zhang J
    Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.
    Du X; Tu Y; Liu S; Zhao P; Bao Z; Li C; Li J; Pan M; Ji J
    J Cell Mol Med; 2020 Jan; 24(2):1474-1487. PubMed ID: 31856394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel biphenyl diester derivative, AB38b, inhibits glioblastoma cell growth via the ROS-AKT/mTOR pathway.
    Meng Q; Zhou J; You F; Wu Y; Yang L; Wang Y; Zhang X; Gao S; Yu R; Yin X
    Biochem Pharmacol; 2021 Dec; 194():114795. PubMed ID: 34687671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
    Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
    Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer effects of FL34 through the inhibition of GLI1 in glioblastoma.
    Li Y; Tang K; Huang L; Liu C; Du Q; Li T; Yan C; Feng Z; Li X
    J Cancer Res Ther; 2019; 15(4):889-898. PubMed ID: 31436248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
    Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
    Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,5-Dimethyl Celecoxib Inhibits Proliferation and Cell Cycle and Induces Apoptosis in Glioblastoma by Suppressing CIP2A/PP2A/Akt Signaling Axis.
    Gao D; Nyalali AMK; Hou Y; Xu Y; Zhou J; Zhao W; Huang B; Li F
    J Mol Neurosci; 2021 Aug; 71(8):1703-1713. PubMed ID: 33400072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.